Skip to main content

Morgan Jess S & Co Inc

SEC CIK
0001133335
Latest filing
Oct 21, 2022

The latest 13F from Morgan Jess S & Co Inc covers Q3 2022 (filed Oct 21, 2022): 36 long positions worth $114.9M. The top 10 holdings make up 47.0% of the portfolio, and the largest is ProShares Tr at 10.5%. Livermore has 7 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q3 2022

Share counts compared with Q2 2022: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
2
Est. +$17.3M
Added
27
Est. +$7.16M
Reduced
6
Est. −$1.41M
Sold out
3
Est. −$3.20M

Top 5 holdings

Share of this quarter's portfolio value

  1. ProShares Tr74347B110
    10.5%$12.1M
  2. Invesco QQQ Trust Series I46090E103
    4.8%$5.46M
  3. Proshares Ultrapro Short Qqq - US ETP74347G432
    4.5%$5.21M
  4. DBCInvesco DB Commodity Index Tracking Fund
    4.3%$4.91MHistory
  5. UNHUnitedHealth Group Inc
    4.1%$4.75MHistory

Share of portfolio

Top 5 holdings and the other 31 positions, by share of portfolio value

  1. ProShares Tr10.5%
  2. Invesco QQQ Trust Series I4.8%
  3. Proshares Ultrapro Short Qqq - US ETP4.5%
  4. DBC4.3%
  5. UNH4.1%
  6. Other 31 positions71.8%

Biggest buys

New and added positions, by estimated amount bought

  1. ProShares Tr74347B110
    +$12.1MNew
  2. Proshares Ultrapro Short Qqq - US ETP74347G432
    +$5.21MNew
  3. State Street Consumer Staples Select Sector SPDR ETF81369Y308
    +$2.82MAdded
  4. AVGOBroadcom Inc.
    +$923.5KAddedHistory
  5. CKPTCheckpoint Therapeutics, Inc.
    +$787.5KAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. ProShares Tr74347B110
    +10.52 pp0.0% → 10.5%
  2. Proshares Ultrapro Short Qqq - US ETP74347G432
    +4.53 pp0.0% → 4.5%
  3. State Street Consumer Staples Select Sector SPDR ETF81369Y308
    +2.22 pp1.0% → 3.2%
  4. ORMPOramed Pharmaceuticals Inc.
    +0.57 pp1.5% → 2.1%History
  5. CKPTCheckpoint Therapeutics, Inc.
    +0.50 pp1.2% → 1.7%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. ADBEAdobe Inc.
    −$2.95MSold outHistory
  2. AXSMAxsome Therapeutics, Inc.
    −$1.16MReducedHistory
  3. INTCIntel Corp
    −$224.0KSold outHistory
  4. First Tr Exchange Trad FD VI33739H101
    −$100.0KReduced
  5. DBCInvesco DB Commodity Index Tracking Fund
    −$92.1KReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. ADBEAdobe Inc.
    −3.05 pp3.1% → 0.0%History
  2. DBCInvesco DB Commodity Index Tracking Fund
    −1.51 pp5.8% → 4.3%History
  3. First Tr Exchange Trad FD VI33739H101
    −1.14 pp5.1% → 4.0%
  4. AXSMAxsome Therapeutics, Inc.
    −1.10 pp4.2% → 3.1%History
  5. iShares Tr464287689
    −0.46 pp2.2% → 1.7%

Metrics

13F metrics for Q3 2022, computed only from the numbers in the filings. Definitions below.

Portfolio value
$114.9M
+$18.5M (+19.2%) vs. prior quarter
Positions
36
−1 vs. prior quarter
Top 10 concentration
47.0%
Top 10 as share of value
Turnover
4.4%
Q3 2022, one quarter
Average holding period
5.3 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

7 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $162.9M (Q4 2021)

Q1 2021: $142.7MQ2 2021: $152.2MQ3 2021: $151.5MQ4 2021: $162.9MQ1 2022: $137.5MQ2 2022: $96.4MQ3 2022: $114.9M
Q1 2021Q3 2022
13F filings of Morgan Jess S & Co Inc by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q3 2022Oct 21, 202236$114.9MProShares TrInvesco QQQ Trust Series IProshares Ultrapro Short Qqq - US ETPvs. Q2 2022SEC
Q2 2022Jul 18, 202237$96.4MDBCInvesco QQQ Trust Series IFirst Tr Exchange Trad FD VIvs. Q1 2022SEC
Q1 2022May 16, 202243$137.5MInvesco QQQ Trust Series IAAPLFirst Tr Exchange Trad FD VIvs. Q4 2021SEC
Q4 2021Jan 27, 202246$162.9MInvesco QQQ Trust Series IAAPLiShares Trvs. Q3 2021SEC
Q3 2021Nov 9, 202141$151.5MInvesco QQQ Trust Series IiShares TrAAPLvs. Q2 2021SEC
Q2 2021Nov 30, 202140$152.2MInvesco QQQ Trust Series IDirexion Shs ETF TrNVCRvs. Q1 2021SEC
Q1 2021Nov 30, 202144$142.7MDirexion Shs ETF TrInvesco QQQ Trust Series IiShares Tr–SEC